Denali Therapeutics Inc.

23.25
0.06 (0.26%)
At close: Jan 28, 2025, 1:50 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 330.53M 108.46M 48.66M 335.66M 26.68M 129.16M n/a n/a n/a
Cost of Revenue 16.73M 7.03M 5.61M 212.62M 193.38M 7.42M 3.08M 1.47M 121.00K
Gross Profit 313.81M 101.43M 43.05M 123.04M -166.70M 121.75M -3.08M -1.47M -121.00K
Operating Income -196.70M -340.74M -295.75M 62.72M -213.18M -46.37M -90.14M -87.43M -16.68M
Interest Income 51.51M 14.77M 4.59M 9.14M 15.22M 10.13M 1.96M 781.00K n/a
Pretax Income -145.19M -325.97M -291.16M 71.96M -197.97M -36.24M -88.19M -86.65M -16.79M
Net Income -145.22M -325.99M -290.58M 71.14M -197.61M -36.24M -88.19M -86.65M -16.79M
Selling & General & Admin 103.35M 90.47M 79.06M 60.33M 46.48M 32.35M 15.68M 11.73M 5.11M
Research & Development 423.88M 358.73M 265.35M 212.62M 193.38M 143.18M 74.46M 75.70M 11.57M
Other Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 527.23M 449.21M 344.41M 272.94M 239.86M 175.53M 90.14M 87.43M 16.68M
Interest Expense n/a 14.77M n/a n/a 15.22M n/a 1.96M n/a 109.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 527.23M 449.21M 344.41M 272.94M 239.86M 175.53M 90.14M 87.43M 16.68M
Income Tax 30.00K 21.00K -575.00K 823.00K -351.00K 10.13M -3.08M n/a n/a
Shares Outstanding (Basic) 137.37M 125.53M 121.52M 108.97M 95.61M 92.62M 14.96M 6.42M 3.01M
Shares Outstanding (Diluted) 137.37M 125.53M 121.52M 112.70M 95.61M 92.62M 14.96M 6.42M 3.01M
EPS (Basic) -1.06 -2.6 -2.39 0.65 -2.07 -0.39 -5.89 -13.49 -5.58
EPS (Diluted) -1.06 -2.6 -2.39 0.63 -2.07 -0.39 -5.89 -13.49 -5.58
EBITDA -179.97M -330.36M -287.16M 62.72M -205.19M -38.96M -87.06M -85.96M -15.06M
Depreciation & Amortization 16.73M 7.03M 5.61M 6.17M 7.99M 7.42M 3.08M 1.47M 121.00K

Create Price Alert on DNLI

Your price alert will notify you when the stock price is above 23.25.

Add to Watchlist